Drug profile · INN
choline fenofibrate
FENOFIBRIC ACID
choline fenofibrate (FENOFIBRIC ACID) is a peroxisome proliferator-activated receptor alpha agonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — choline fenofibrate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
choline fenofibrate (FENOFIBRIC ACID) is a peroxisome proliferator-activated receptor alpha agonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Peroxisome proliferator-activated receptor alpha agonist
Primary target: Peroxisome proliferator-activated receptor alpha
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is choline fenofibrate?
choline fenofibrate (FENOFIBRIC ACID) is a peroxisome proliferator-activated receptor alpha agonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for choline fenofibrate?
FENOFIBRIC ACID is a marketed brand name for choline fenofibrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of choline fenofibrate?
choline fenofibrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.